D2 Pharma Consulting is Consulting Services (B2B) in United States that focus on product commercialization strategies business. Founded in 2008. They cover business area such as provider, turn-key commercialization service, bio-pharmaceutical company, strategic business and technology planning, organizational and infrastructure analysis, manage care sale support, new product commercialization strategy.
2008
( 16 years old in 2024 )
Product Commercialization Strategies
-
6209 Mid Rivers Mall Drive
Suite 125
Saint Charles, MO 63304
United States
Private
providerturn-key commercialization servicebio-pharmaceutical companystrategic business and technology planningorganizational and infrastructure analysismanage care sale supportnew product commercialization strategy
* We use standard office opening hours in near D2 Pharma Consulting's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
D2 Pharma Consulting is Consulting Services (B2B) business from United States that founded in 2008 (16 years old in 2024), D2 Pharma Consulting business is focusing on Product Commercialization Strategies.
D2 Pharma Consulting headquarter office and corporate office address is located in 6209 Mid Rivers Mall Drive Suite 125 Saint Charles, MO 63304 United States.
D2 Pharma Consulting was founded in United States.
In 2024, D2 Pharma Consulting is currently focus on product commercialization strategies sector.
Above is snippet of Google Trends for "product commercialization strategies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with D2 Pharma Consulting, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
